The important role of serology for COVID-19 control

AK Winter, ST Hegde - The Lancet infectious diseases, 2020 - thelancet.com
The Lancet infectious diseases, 2020thelancet.com
As of April 14, 2020, just under 2 million cases of coronavirus disease 2019 (COVID-19)
have been reported worldwide. 1 With the pandemic growing at an alarming rate and
national governments struggling to control local epidemics because of scant diagnostics and
impermanent non-pharmaceutical interventions, we should look to additional
epidemiological solutions. Locations such as Singapore and Taiwan have been successful
in slowing epidemic growth by using intensive surveillance with broader testing strategies to …
As of April 14, 2020, just under 2 million cases of coronavirus disease 2019 (COVID-19) have been reported worldwide. 1 With the pandemic growing at an alarming rate and national governments struggling to control local epidemics because of scant diagnostics and impermanent non-pharmaceutical interventions, we should look to additional epidemiological solutions. Locations such as Singapore and Taiwan have been successful in slowing epidemic growth by using intensive surveillance with broader testing strategies to identify and contain cases. 2, 3
In The Lancet Infectious Diseases, Sarah Ee Fang Yong and colleagues4 report three clusters of COVID-19 cases identified in Singapore in early 2020 by active case-finding and contact tracing and confirmed with RT-PCR. One cluster from a church (Church A) was previously identified5 and linked to two imported cases from Wuhan, China. The two additional clusters (Church B and a family gathering) were attributable to community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by one individual interacting with both clusters. Serological platforms were
thelancet.com